Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04748848
Title A Safety, Tolerability and Preliminary Efficacy Study of CC-90011 in Combination With Venetoclax and Azacitidine in R/R Acute Myeloid Leukemia and Treatment-naïve Participants Not Eligible for Intensive Therapy
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Celgene
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP | BEL

Facility Status City State Zip Country Details
Local Institution - 110 Duarte California 91010-301 United States Details
Local Institution - 103 New Haven Connecticut 06510 United States Details
Local Institution - 108 Miami Florida 33136 United States Details
Local Institution - 111 Chicago Illinois 60611 United States Details
Local Institution - 121 New York New York 10029 United States Details
Local Institution - 118 Durham North Carolina 27710 United States Details
Local Institution - 116 Cleveland Ohio 44195 United States Details
Local Institution - 115 Columbus Ohio 43210 United States Details
Local Institution - 104 Dallas Texas 75246 United States Details
Local Institution - 101 Houston Texas 77030 United States Details
Local Institution - 120 Seattle Washington 98104 United States Details
Local Institution - 202 Gent 9000 Belgium Details
Local Institution - 401 Villejuif CEDEX 94805 France Details
Local Institution - 803 Barcelona 08035 Spain Details
Local Institution - 800 Barcelona 08907 Spain Details
Local Institution - 802 Madrid 28007 Spain Details
Local Institution - 801 Sevilla 41013 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field